title: Omega-3 fatty acids and cardiovascular disease.
abstract: Cardioceuticals are nutritional supplements that contain all the essential nutrients including vitamins, minerals, omega-3-fatty acids and other antioxidants like a-lipoic acid and coenzyme Q10 in the right proportion that provide all round protection to the heart by reducing the most common risks associated with the cardiovascular disease including high low-density lipoprotein cholesterol and triglyceride levels and factors that contribute to coagulation of blood. Omega-3 fatty acids have been shown to significantly reduce the risk for sudden death caused by cardiac arrhythmias and all-cause mortality in patients with known coronary heart disease. Omega-3 fatty acids are also used to treat hyperlipidemia and hypertension. There are no significant drug interactions with omega-3 fatty acids. The American Heart Association recommends consumption of two servings of fish per week for persons with no history of coronary heart disease and at least one serving of fish daily for those with known coronary heart disease. Approximately 1 g/day of eicosapentaenoic acid plus docosahexaenoic acid is recommended for cardio protection. Higher dosages of omega-3 fatty acids are required to reduce elevated triglyceride levels (2-4 g/day). Modest decreases in blood pressure occur with significantly higher dosages of omega-3 fatty acids.
authors.affiliation: Department of Medicine, MGIMS, Wardha, India. mwlj521@163.com.
authors.forename: A P
authors.initials: AP
authors.lastname: Jain
authors.forename: K K
authors.initials: KK
authors.lastname: Aggarwal
authors.forename: P-Y
authors.initials: PY
authors.lastname: Zhang
mesh_terms: D000572:American Heart Association; D000818:Animals; D002318:Cardiovascular Diseases / Q000097:blood / Q000175:diagnosis* / Q000517:prevention & control*; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000008:administration & dosage; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage*; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism; D008297:Male; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D014481:United States
chemical_list: D015525:Fatty Acids, Omega-3; D008077:Lipoproteins, LDL; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid